With newborn screening expansion, rising diagnosis rates, and regulatory support for orphan therapies, the neuromuscular disease therapeutics market is gaining significant momentum. https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html